Daliom Biopharmaceuticals focused on developing innovative solutions to improve health outcomes

The company's product range includes:

Our Products

Diagnostic tools

Diagnostic tools


Daliom Biopharmaceuticals develops diagnostic tools to help clinicians identify diseases earlier and more accurately. Their range of diagnostic tools includes rapid diagnostic tests for infectious diseases, as well as more sophisticated molecular diagnostic solutions for cancer, genetic disorders, and autoimmune diseases. More >>
 

Therapeutic proteins 

Therapeutic proteins


Daliom Biopharmaceuticals develops therapeutic proteins, such as monoclonal antibodies and recombinant proteins, to treat a range of diseases. This includes immunotherapy for cancer, as well as treatments for autoimmune disorders, rare diseases, and infectious diseases. More >>
 

Vaccine development

Vaccine development
Daliom Biopharmaceuticals is also involved in vaccine development, with a focus on developing innovative vaccine technologies that can improve the efficacy of existing vaccines and help address emerging infectious diseases. More >>
 

Drug delivery systems

Drug delivery systems
Daliom Biopharmaceuticals develops drug delivery systems to help improve the efficacy and safety of existing drugs. This includes developing novel drug delivery technologies that can target specific cells or tissues in the body, as well as developing more effective routes of administration for existing drugs. More >>
 

Dietary supplements and probiotics 

dietary supplements, and probiotics


Daliom Biopharmaceuticals' comprehensive range of biopharmaceutical products, dietary supplements, and probiotics are designed to support overall health and wellbeing, by addressing specific health concerns and improving patient outcomes. More>>

TOP

We refuse unauthorized email collection

Close

We refuse the unauthorized collection of the email addresses on this website using email collection programs or other technical devices. Please note that any violation will be subject to criminal penalties in accordance with the Act on Information and Communications Network.

Posted on March 28, 2023

Cookie Popup Close
Manage Cookies

This site uses cookies.
By continuing to browse the site,
you agree to the use of cookies.

Privacy Policy Accept